Page 787 - Read Online
P. 787

Stolz et al. Mini-invasive Surg 2020;4:76  I  http://dx.doi.org/10.20517/2574-1225.2020.69                                        Page 13 of 14

                   comparative analysis of different EuroSCORE strata. EuroIntervention 2012;8:571-8.
               37.  Yzeiraj E, Bijuklic K, Tiburtius C, et al. Tricuspid regurgitation is a predictor of mortality after percutaneous mitral valve edge-to-edge
                   repair. EuroIntervention 2017;12:e1817-24.
               38.  Itabashi Y, Utsunomiya H, Kubo S, et al. Different indicators for postprocedural mitral stenosis caused by single- or multiple-clip
                   implantation after percutaneous mitral valve repair. J Cardiol 2018;71:336-45.
               39.  Watanabe N, Ogasawara Y, Yamaura Y, et al. Mitral annulus flattens in ischemic mitral regurgitation: geometric differences between
                   inferior and anterior myocardial infarction: a real-time 3-dimensional echocardiographic study. Circulation 2005;112:I458-62.
               40.  El Sebaie MH, Abdelatti MN, Zarea AA, et al. Assessment of mitral valve geometric deformity in patients with ischemic heart disease
                   using three-dimensional echocardiography. Egypt Heart J 2017;69:13-20.
               41.  Stolfo D, De Luca A, Morea G, et al. Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced
                   heart failure: Implications for patient selection. Int J Cardiol 2018;257:182-7.
               42.  Kalbacher D, Schäfer U, V Bardeleben RS, et al. Long-term outcome, survival and predictors of mortality after MitraClip therapy:
                   Results from the German Transcatheter Mitral Valve Interventions (TRAMI) registry. Int J Cardiol 2019;277:35-41.
               43.  Bannehr M, Kahn U, Okamoto M, et al. Post-procedural tricuspid regurgitation predicts long-term survival in patients undergoing
                   percutaneous mitral valve repair. J Cardiol 2019;74:524-31.
               44.  Buzzatti N, De Bonis M, Denti P, et al. What is a “good” result after transcatheter mitral repair? Impact of 2+ residual mitral regurgitation.
                   J Thorac Cardiovasc Surg 2016;151:88-96.
               45.  Rudolph V, Lubos E, Schlüter M, et al. Aetiology of mitral regurgitation differentially affects 2-year adverse outcomes after MitraClip
                   therapy in high-risk patients. Eur J Heart Fail 2013;15:796-807.
               46.  Azzalini L, Millán X, Khan R, et al. Impact of left ventricular function on clinical outcomes of functional mitral regurgitation patients
                   undergoing transcatheter mitral valve repair. Catheter Cardiovasc Interv 2016;88:1124-33.
               47.  Baldi C, Citro R, Silverio A, et al. Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing
                   MitraClip treatment. Int J Cardiol 2019;284:50-8.
               48.  Godino C, Scotti A, Taramasso M, et al. Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in
                   ischemic and non-ischemic dilated cardiomyopathy. Int J Cardiol 2018;269:33-9.
               49.  De Bonis M, Taramasso M, Lapenna E, et al. MitraClip therapy and surgical edge-to-edge repair in patients with severe left ventricular
                   dysfunction and secondary mitral regurgitation: mid-term results of a single-centre experience. Eur J Cardiothorac Surg 2016;49:255-62.
               50.  Bartko PE, Heitzinger G, Arfsten H, et al. Disproportionate functional mitral regurgitation: advancing a conceptual framework to clinical
                   practice. JACC Cardiovasc Imaging 2019;12:2088-90.
               51.  Keßler M, Pott A, Mammadova E, et al. Atrial fibrillation predicts long-term outcome after transcatheter edge-to-edge mitral valve repair
                   by MitraClip implantation. Biomolecules 2018;8:152.
               52.  Iliadis C, Baldus S, Kalbacher D, et al. Impact of left atrial diameter on outcome in patients undergoing edge-to-edge mitral valve repair:
                   results from the German TRAnscatheter Mitral valve Interventions (TRAMI) registry. Eur J Heart Fail 2020:22:1202-10.
               53.  Ledwoch J, Leidgschwendner K, Fellner C, et al. Prognostic impact of left atrial function following transcatheter mitral valve repair. J Am
                   Heart Assoc 2019;8:e011727.
               54.  Deferm S, Bertrand PB, Verbrugge FH, et al. Atrial functional mitral regurgitation: JACC review topic of the week. J Am Coll Cardiol
                   2019;73:2465-76.
               55.  Neuss M, Schau T, Isotani A, et al. Elevated mitral valve pressure gradient after MitraClip implantation deteriorates long-term outcome in
                   patients with severe mitral regurgitation and severe heart failure. JACC Cardiovasc Interv 2017;10:931-9.
               56.  Boerlage-vanDijk K, Wiegerinck EM, Araki M, et al. Predictors of outcome in patients undergoing MitraClip implantation: an aid to
                   improve patient selection. Int J Cardiol 2015;189:238-43.
               57.  Puls M, Tichelbäcker T, Bleckmann A, et al. Failure of acute procedural success predicts adverse outcome after percutaneous edge-to-
                   edge mitral valve repair with MitraClip. EuroIntervention 2014;9:1407-17.
               58.  Puls M, Tichelbäcker T, Bleckmann A, et al. Failure of acute procedural success predicts adverse outcome after percutaneous edge-to-
                   edge mitral valve repair with MitraClip. EuroIntervention 2014;9:1407-17.
               59.  Sürder D, Pedrazzini G, Gaemperli O, et al. Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the
                   results of the MitraSwiss registry. Heart 2013;99:1034-40.
               60.  Capodanno D, Adamo M, Barbanti M, et al; GRASP-IT Investigators. Predictors of clinical outcomes after edge-to-edge percutaneous
                   mitral valve repair. Am Heart J 2015;170:187-95.
               61.  Patzelt J, Zhang W, Sauter R, et al. Elevated mitral valve pressure gradient is predictive of long-term outcome after percutaneous
                   edge-to-edge mitral valve repair in patients with degenerative mitral regurgitation (MR), but not in functional MR. J Am Heart Assoc
                   2019;8:e011366.
               62.  Alessandrini H, Kreidel F, Schlüter M, et al. Prognostic implication of post-MitraClip vena contracta area in heart failure patients with
                   functional mitral regurgitation. EuroIntervention 2017;12:1946-53.
               63.  Taramasso M, Denti P, Latib A, et al. Clinical and anatomical predictors of MitraClip therapy failure for functional mitral regurgitation:
                   single central clip strategy in asymmetric tethering. Int J Cardiol 2015;186:286-8.
               64.  Kitamura M, Kaneko H, Schlüter M, et al. Predictors of mortality in ischaemic versus non-ischaemic functional mitral regurgitation after
                   successful transcatheter mitral valve repair using MitraClip: results from two high-volume centres. Clin Res Cardiol 2019;108:264-72.
               65.  Hoit BD. Atrial functional mitral regurgitation: the left atrium gets its due respect. J Am Coll Cardiol 2011;58:1482-4.
               66.  Kagiyama N, Mondillo S, Yoshida K, Mandoli GE, Cameli M. Subtypes of atrial functional mitral regurgitation: imaging insights into
   782   783   784   785   786   787   788   789   790   791   792